These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of scopolamine on interhemispheric EEG coherence in healthy subjects: analysis during rest and photic stimulation. Kikuchi M; Wada Y; Koshino Y; Nanbu Y; Hashimoto T Clin Electroencephalogr; 2000 Apr; 31(2):109-15. PubMed ID: 10840634 [TBL] [Abstract][Full Text] [Related]
7. [The effect of scopolamine on the spatial organization of rat cortical potentials]. Koshtoiants OKh; Korol'kova TA; Kozhechkin SN; Kozhedub RG; Sviderskaia NE; Petukhova EG; Balashova AN Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(6):1052-6. PubMed ID: 10693286 [TBL] [Abstract][Full Text] [Related]
8. Spectral analysis of heart rate variability as a quantitative measure of parasympatholytic effect--integrated pharmacokinetics and pharmacodynamics of three anticholinergic drugs. Scheinin H; Helminen A; Huhtala S; Grönroos P; Bosch JA; Kuusela T; Kanto J; Kaila T Ther Drug Monit; 1999 Apr; 21(2):141-51. PubMed ID: 10217331 [TBL] [Abstract][Full Text] [Related]
9. EEG changes following scopolamine administration in healthy subjects. Quantitative analysis during rest and photic stimulation. Kikuchi M; Wada Y; Nanbu Y; Nakajima A; Tachibana H; Takeda T; Hashimoto T Neuropsychobiology; 1999 May; 39(4):219-26. PubMed ID: 10343188 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers. Ebert U; Grossmann M; Oertel R; Gramatté T; Kirch W J Clin Pharmacol; 2001 Jan; 41(1):51-60. PubMed ID: 11144994 [TBL] [Abstract][Full Text] [Related]
11. Muscarinic and N-methyl-D-aspartate receptor blockade reveal differences in hippocampal local field potentials in mice with low cholinergic tone. Leung LS; Moallem S; Prado MAM; Prado VF; Chu L Hippocampus; 2022 Oct; 32(10):731-751. PubMed ID: 36123765 [TBL] [Abstract][Full Text] [Related]
13. The influence of methylphenidate on the power spectrum of ADHD children - an MEG study. Wienbruch C; Paul I; Bauer S; Kivelitz H BMC Psychiatry; 2005 Jul; 5():29. PubMed ID: 16042816 [TBL] [Abstract][Full Text] [Related]
14. TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys. Kurimoto E; Nakashima M; Kimura H; Suzuki M PLoS One; 2019; 14(3):e0207969. PubMed ID: 30856192 [TBL] [Abstract][Full Text] [Related]
15. Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer's disease. Bajo R; Pusil S; López ME; Canuet L; Pereda E; Osipova D; Maestú F; Pekkonen E Sci Rep; 2015 Jul; 5():9748. PubMed ID: 26130273 [TBL] [Abstract][Full Text] [Related]
16. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers. Dukoff R; Wilkinson CW; Lasser R; Friz J; Conway A; Bahro M; Peskind ER; Sunderland T Biol Psychiatry; 1999 Jul; 46(2):189-95. PubMed ID: 10418693 [TBL] [Abstract][Full Text] [Related]
17. Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade. Voss B; Thienel R; Reske M; Habel U; Kircher T Eur Arch Psychiatry Clin Neurosci; 2010 Nov; 260 Suppl 2():S106-10. PubMed ID: 20960003 [TBL] [Abstract][Full Text] [Related]
18. Probing peripheral and central cholinergic system responses. Naranjo CA; Fourie J; Herrmann N; Lanctôt KL; Birt C; Yau KK J Psychiatry Neurosci; 2000 Sep; 25(4):325-36. PubMed ID: 11022397 [TBL] [Abstract][Full Text] [Related]